(Q51836177)

English

Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.

scientific article published on 23 January 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

1 reference

ChEBI release 2020-05-28

author name string

Douglas L Seidner

1

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Lauren K Schwartz

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Marion F Winkler

3

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Khursheed Jeejeebhoy

4

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Joseph I Boullata

5

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Kelly A Tappenden

6

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

publication date

23 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Journal of Parenteral and Enteral Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

37

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

2

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

201-211

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

Short bowel syndrome and intestinal failure: consensus definitions and overview

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Current management of the short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Dietary and medical management of short bowel syndrome in adult patients

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Etiology and initial management of short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Intestinal rehabilitation and the short bowel syndrome: part 2.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Glucagon-like Peptide-2.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Management of short bowel syndrome: avoidance of total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Guidelines for management of home parenteral support in adult chronic intestinal failure patients

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Intestinal adaptation after massive intestinal resection

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Mechanisms of enteral nutrient-enhanced intestinal adaptation

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: a positive study.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Effect of cholestyramine on the absorption of vitamin D3 and calcium

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Small bowel bacterial overgrowth in adults: a potential contributor to intestinal failure

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Glucagon-like peptide-2 increases mesenteric blood flow in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Strategies for parenteral nutrition weaning in adult patients with short bowel syndrome

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

The Role of Anatomic Factors in Nutritional Autonomy After Extensive Small Bowel Resection

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients

1 reference

https://api.crossref.org/works/10.1177%2F0148607112472906

21 January 2018

Identifiers

10.1177/0148607112472906

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 April 2018

http://europepmc.org/abstract/MED/23343999

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51836177&oldid=2139903517"